IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company” or “IP Strategy”), the first company to adopt a treasury reserve ...

“This share repurchase authorization reflects our confidence in the Company’s fundamentals,” said Guardforce AI Chairwoman and CEO Lei Wang. “We are building our future on a foundation of real revenue ...

Walmart's board has approved a new $30 billion share-repurchase program. Walmart on Thursday said the new authorization replaces a $20 billion program announced in late 2022 under which it shelled out ...

KANZHUN LIMITED (“BOSS Zhipin”or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share ...

Q4 2025 Management View CEO David Morken reported a solid fourth quarter, emphasizing "sustained business performance and strengthening fundamentals." He highlighted record $1 million-plus enterprise ...

Guardforce AI GFAI stock rose Friday as the company announced a new share repurchase program aimed at enhancing long-term value. GFAI Launches $5M Share Buyback Program The Board of Directors at ...

Q4 2025 Management View CEO Nirav Patel began by reaffirming the company's transformation priorities and highlighted, "We believe we have made meaningful progress across each of these priorities." He ...

Shares of Upwork jumped after the company approved a $300 million share repurchase program. The stock climbed 8% to $13.77 in midday Wednesday trading. The shares have retreated nearly 19% in the past ...

In recent days, Sea Limited has drawn attention after ARK Invest’s ETFs and other institutional investors increased their holdings, alongside the board authorizing a US$1.00 billion share repurchase ...

AMSTERDAM, Dec. 12, 2025 /PRNewswire/ -- Ferrovial SE ("Ferrovial" or the "Company", Ticker: "FER") announces that it has resolved to terminate, with effect from today's closing of the U.S. stock ...

RANCHO CUCAMONGA, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) ('iPower” or the 'Company”) today ...

BERKELEY HEIGHTS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...